PHARMACY COUNCIL OF INDIA CONSTITUTED ADVISORY EXPERT COMMITTEE OF INDUSTRY TO BRIDGE ACADEMIA AND PHARMA SECTOR GAP.
PHARMACY COUNCIL OF INDIA CONSTITUTED ADVISORY EXPERT COMMITTEE OF INDUSTRY TO BRIDGE ACADEMIA AND PHARMA SECTOR GAP.
The Pharmacy Council of India (PCI) has announced the constitution of a high-level Advisory Expert Committee of Industry, appointing Mr. Bodh Raj Sikri as its Chairman. Mr. B. R. Sikri is a distinguished leader in the pharmaceutical sector, serving as the Chairman of FOPE, Vice President of BDMA, Chairman of the LOC for the 75th IPC, and a prominent figure across numerous other key organizations.
This initiative, spearheaded under the leadership of PCI President Dr. Montu Patel, Vice President Mr. Jashubhai Chaudhari, and EC Member Dr. Atul Nasa, aims to foster stronger collaboration among regulatory bodies, academic institutions, and the pharmaceutical industry.
To guide the PCI effectively, Mr. Sikri was authorized to form his team. Accordingly, he announced Dr. Atul Nasa as the Vice Chairman, along with a panel of 34 esteemed experts from industry and regulatory backgrounds. We are delighted to share that you are one of the distinguished members inducted into this committee. In constituting this body, Mr. Sikri has ensured comprehensive representation across all key sectors, including Production, R&D, QC, QA, Excipients, APIs, Vaccines, Packaging, Retail, Marketing, Cosmetics, Institutional Business, MSMEs, Medium & Large-Scale Enterprises, the Organized Sector, and Regulatory Markets.
Key Highlights & Committee Mandate
Leadership & Term: The committee will operate for a two-year tenure, holding its meetings primarily at the PCI Headquarters in New Delhi. In the absence of the Chairman, the Vice Chairman will preside over the proceedings, with Mr. Harish Jain designated to act as Vice Chairman when required.
Ex-Officio Appointments: To maintain strong alignment with regulatory standards, three key Ex-Officio positions have been inducted:
- Drugs Controller General of India (DCGI)
- President, Pharmacy Council of India
- Vice President, Pharmacy Council of India
Coordination Team: Ms. Neeti Arora (Pharmacy graduate and MBA, Wings Group) will serve as Coordinator alongside Mr. Sunil Ahuja (Former Director, Ranbaxy, and present Director General, FOPE).
Upcoming Meeting: The committee’s next formal session is scheduled to take place in the third or fourth week of January 2027 at the PCI Delhi Office.
Industry Collaboration & Support
The PCI extends its sincere appreciation to major national pharmaceutical and healthcare associations—including IPA, IDMA, OPPI, BDMA, FOPE, CIPI, Laghu Udyog Bharati, AiMeD (Medical Device Association), and RDCA (Chemist Association)—for nominating their representatives to support this national initiative. Special recognition is also extended to the Central Drugs Standard Control Organization (CDSCO) for deputing Mr. Arvind Kukrety, Deputy DCGI, to the panel.
Speaking on the announcement, the PCI leadership emphasized that the recommendations generated by this advisory body will play a crucial role in shaping industry-aligned policies, enhancing curriculum relevance, and advancing professional skills across the Indian pharmaceutical sector.
